Stocks That Hit 52-Week Lows On Friday
Before 10 am on Friday, 110 companies set new 52-week lows.
Roth Capital Initiates Coverage On BioAtla with Buy Rating, Announces Price Target of $75
Roth Capital analyst Tony Butler initiates coverage on BioAtla (NASDAQ:BCAB) with a Buy rating and announces Price Target of $75.
60 Biggest Movers From Yesterday
Gainers
RAPT Therapeutics, Inc. (NASDAQ: RAPT) shares jumped 115.5% to settle at $40.02 on Monday as the company announced topline results from its Phase 1b trial of RPT193 as monotherapy for moderate-to-severe atopic dermatitis (AD).
40 Stocks Moving In Monday’s Mid-Day Session
Gainers
Enochian Biosciences, Inc. (NASDAQ: ENOB) shares jumped 127.2% to $10.02. The FDA has accepted Enochian BioSciences Inc's pre-IND (Investigational New Drug) request for a potential functional cure or treatment of HIV.